Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Boston Pace Study

NCT: NCT05869500 · ACTIVE_NOT_RECRUITING

NCT IDNCT05869500
StatusACTIVE_NOT_RECRUITING
Start Date2023-05-01
Completion2026-06-30

Brief Summary

Right ventricular (RV) pacing can cause left ventricular systolic dysfunction in 10- 20% of patients. Biventricular pacing had previously been shown to prevent left ventricular systolic dysfunction. However, implantation of coronary sinus lead increases procedural risk and can be limited by higher threshold and phrenic nerve capture. HIS pacing has been evaluated as an alternative pacing strategy, but its routine use was limited by difficulty of the procedure, success rate and high pacing threshold. Left bundle branch area pacing (LBBAP) is a promising physiologic pacing technique that has been proposed as a pacing strategy to prevent pacing induced cardiomyopathy and for treatment of desynchrony in heart failure. LBBAP has been adopted widely and performed routinely on patients with AV block. Currently, it is up to the discretion of the proceduralist whether LBBAP is performed given that there is lack of evidence to guide pacing strategies.

Frequently Asked Questions

What is The Boston Pace Study?

The Boston Pace Study is a clinical trial registered under NCT05869500. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05869500?

The current status of NCT05869500 (The Boston Pace Study) is: ACTIVE_NOT_RECRUITING.

When did The Boston Pace Study start?

The Boston Pace Study started on 2023-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.